AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.880
+0.030 (1.05%)
Mar 23, 2026, 4:00 PM EDT - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $293.11 million as of March 23, 2026. Its market cap has increased by 21.82% in one year.
Market Cap
293.11M
Enterprise Value
183.55M
1-Year Change
21.82%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $293.11M, a decrease of -66.21%. That is a compound annual growth rate of -10.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 293.00M | -7.51% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 303.23M |
| Crescent Biopharma | 300.37M |
| NovaBridge Biosciences | 295.15M |
| Neurogene | 295.08M |
| Forte Biosciences | 294.38M |
| Foghorn Therapeutics | 293.50M |
| Climb Bio | 291.86M |
| Silence Therapeutics | 291.43M |